Stock Price
2.49
Daily Change
0.02 0.81%
Monthly
-9.78%
Yearly
-21.94%
Q1 Forecast
2.48

Mesoblast reported $102.63M in Current Liabilities for its fiscal semester ending in June of 2025.





Current Liabilities Change Date
Avita Medical AUD 62.6M 42.44M Jun/2025
Clinuvel Pharmaceuticals AUD 25.21M 4.17M Jun/2024
Cochlear AUD 602.3M 23.8M Jun/2025
CSL USD 4.82B 1.26B Jun/2025
Pacific Edge NZD 7.22M 2.54M Dec/2025
Paradigm Biopharmaceuticals AUD 3.23M 2.15M Jun/2025
PYC Therapeutics AUD 12.32M 939.58K Jun/2025
Ramsay Health Care AUD 4.47B 750.4M Jun/2025
Sonic Healthcare AUD 2.23B 92.84M Dec/2024
Starpharma Holdings AUD 5.23M 378K Jun/2025
Telix Pharmaceuticals AUD 330.91M 72.54M Dec/2024